ModivCare Inc. (NASDAQ:MODV) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Company Participants Kevin Ellich - Head of IR Heath Sampson - President and CEO Barbara Gutierrez - CFO Conference Call Participants Pito Chickering - Deutsche Bank Bob Labick - CJS Securities Scott Fidel - Stephens Brooks O'Neil - Lake Street Capital Mike Petusky - Barrington Research Operator Good morning, and welcome to ModivCare's Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please ...

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware 86-0845127 (State or other jurisdiction ...

ModivCare Inc. (NASDAQ:MODV) Q2 2023 Results Conference Call August 4, 2023 8:30 AM ET Company Participants Kevin Ellich - Head of Investor Relations Heath Sampson - President and Chief Executive Officer Kenneth Shepard - Vice President and Chief Accounting Officer Conference Call Participants Robert Labick - CJS Securities Brian Tanquilut - Jefferies Scott Fidel - Stephens Inc Aaron Wukmir - Lake Street Capital Markets Philip Chickering - Deutsche Bank AG Michael Petusky - Barrington Research Associates Mi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of ( ...

GMM Reported Revenue (Pre-Acquisition) 6,487 Consolidated Pro Forma Revenue $2,510,880 Twelve Months Ended Dec 31, | --- | --- | |-------|----------| | 2022 | | | | $221,902 | | | | | | $224,351 | (dollars in thousands) Consolidated Adj. EBITDA Consolidated Pro Forma Adj. EBITDA | --- | --- | |---------------------------------------------------------|---------------| | | | | Pro Forma Remote Patient Monitoring Segment Revenue | Twelve Months | | | Ended Dec 31, | | (dollars in thousands) | 2022 | | Modivcar ...

ModivCare Inc. (NASDAQ:MODV) Q1 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Kevin Ellich - Head, Investor Relations Heath Sampson - President, Chief Executive Officer and Chief Financial Officer Ken Shepard - Head of Finance Conference Call Participants Brian Tanquilut - Jefferies Bob Labick - CJS Securities Scott Fidel - Stephens Pito Chickering - Deutsche Bank Miles Highsmith - Deutsche Bank Mike Petusky - Barrington Research Operator Good morning and welcome to ModivCare's F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of ...

|██ modivcare Forward Looking Statements In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this investor presentation includes presentations of EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin for the Company and its segments, pro forma presentations of such financial measures that adjust for the acquisitions identified herein, and EBITDA and Adjusted EBITDA for the Company's Matrix equity investment, which are perfor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of (I.R. ...

ModivCare Inc. (NASDAQ:MODV) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Kevin Ellich - Head, IR Heath Sampson - President, Chief Executive Officer and Chief Financial Officer Kenneth Shepard - CFO of Mobility Scott Kern - CFO of Home Conference Call Participants Brian Tanquilut - Jefferies Peter Lukas - CJS Securities Brooks O'Neil - Lake Street Capital Scott Fidel - Stephens Inc. Kieran Ryan - Deutsche Bank Michael Petusky - Barrington Research Operator Good morni ...